» Articles » PMID: 37864300

Novel, Pathogenic Insertion Variant of GSDME Associates with Autosomal Dominant Hearing Loss in a Large Chinese Pedigree

Overview
Journal J Cell Mol Med
Date 2023 Oct 21
PMID 37864300
Authors
Affiliations
Soon will be listed here.
Abstract

Nonsyndromic hearing loss (NSHL) is a genetically diverse, highly heterogeneous condition characterised by deafness, and Gasdermin E (GSDME) variants have been identified as directly inducing autosomal dominant NSHL. While many NSHL cases associated with GSDME involve the skipping of exon 8, there is another, less understood pathogenic insertion variant specifically found in Chinese pedigrees that causes deafness, known as autosomal dominant 5 (DFNA5) hearing loss. In this study, we recruited a large Chinese pedigree, conducted whole-exome and Sanger sequencing to serve as a comprehensive clinical examination, and extracted genomic DNA samples for co-segregation analysis of the members. Conservation and expression analyses for GSDME were also conducted. Our clinical examinations revealed an autosomal dominant phenotype of hearing loss in the family. Genetic analysis identified a novel insertion variant in GSDME exon 8 (GSDME: NM_004403.3: c.1113_1114insGGGGTGCAGCTTACAGGGTGGGTGT: p. P372fs*36). This variant is segregated with the deafness phenotype of this pedigree. The GSDME gene was highly conserved in the different species we analysed, and its mRNA expression was ubiquitously low in different human tissues. In conclusion, we have successfully identified a novel pathogenic insertion variant of GSDME in a Chinese pedigree that causes deafness, shedding light on the genetic basis of hearing loss within this specific family. Our findings expand the spectrum of known variants associated with GSDME-related deafness and may further support both the underlying gain-of-function mechanism and functional associations of GSDME hearing loss variants.

Citing Articles

Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers.

Fu J, Li D, Zhang L, Maghsoudloo M, Cheng J, Fu J Cancer Cell Int. 2024; 24(1):279.

PMID: 39118110 PMC: 11312966. DOI: 10.1186/s12935-024-03467-2.


The gasdermin family: emerging therapeutic targets in diseases.

Zhu C, Xu S, Jiang R, Yu Y, Bian J, Zou Z Signal Transduct Target Ther. 2024; 9(1):87.

PMID: 38584157 PMC: 10999458. DOI: 10.1038/s41392-024-01801-8.


The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.

Liu K, Fu J, Guo K, Maghsoudloo M, Cheng J, Fu J Genes (Basel). 2024; 15(3).

PMID: 38540362 PMC: 10970080. DOI: 10.3390/genes15030304.


Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree.

Cheng J, Li T, Tan Q, Fu J, Zhang L, Yang L J Cell Mol Med. 2023; 28(1):e18004.

PMID: 37864300 PMC: 10805510. DOI: 10.1111/jcmm.18004.

References
1.
Yu C, Meng X, Zhang S, Zhao G, Hu L, Kong X . A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics. 2003; 82(5):575-9. DOI: 10.1016/s0888-7543(03)00175-7. View

2.
Liu Y, Tan M, Cai L, Lv L, Chen Q, Chen W . Genetic profiles of non-syndromic severe-profound hearing loss in Chinese Hans by whole-exome sequencing. Gene. 2022; 819:146258. DOI: 10.1016/j.gene.2022.146258. View

3.
Cheng J, Li T, Tan Q, Fu J, Zhang L, Yang L . Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree. J Cell Mol Med. 2023; 28(1):e18004. PMC: 10805510. DOI: 10.1111/jcmm.18004. View

4.
Cheng J, Han D, Dai P, Sun H, Tao R, Sun Q . A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family. Clin Genet. 2007; 72(5):471-7. DOI: 10.1111/j.1399-0004.2007.00889.x. View

5.
Alford R, Arnos K, Fox M, Lin J, Palmer C, Pandya A . American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss. Genet Med. 2014; 16(4):347-55. DOI: 10.1038/gim.2014.2. View